Literature DB >> 23578437

[Infective endocarditis in sub-Saharan african children, cross-sectional study about 19 cases in Ouagadougou at Burkina Faso].

N V Yameogo1, K J Kologo2, A A Yameogo2, C Yonaba2, G R C Millogo2, S A Kissou2, B J Y Toguyeni2, A K Samadoulougou2, S Pignatelli2, J Simpore2, P Zabsonre2.   

Abstract

INTRODUCTION: Infective endocarditis is a transplant of a microorganism on a most often injured endocardium. It is rare in children. This work aimed to determine the frequency of endocarditis of the child, to describe clinical presentation, data from echocardiography, microbiological profile and clinical course. PATIENTS AND METHODS: From May 1 2010 to April 30 2011, we consecutively included children received for infective endocarditis in two medical centers in the city of Ouagadougou: Saint-Camille medical center and teaching hospital Yalgado-Ouedraogo. We investigated the functional and general signs and treatment already received. The physical examination looking for an infectious syndrome, pneumonia, heart failure and entrance doors. Blood cultures, blood count, creatinine, blood chemistry, HIV status, electrocardiogram, chest radiography and cardiac Doppler ultrasound were systematic. The diagnosis of the disease was based on Duke criteria.
RESULTS: Nineteen endocarditis in children were reported, that is 1.7% of admissions. The average age was 4.7 ± 2.6 years (extremes: 1 and 14). The sex ratio was 1.7 for girls. The clinical presentation was a common infectious syndrome. Impaired general condition and congestive heart failure were present on admission in six cases, respectively. The front door was dental in nine cases (47.4%), skin in four cases (21%) and ENT in three cases (15.8%). A peripheral vein was implicated in one case. In the two other cases, no front door had been found. HIV serology was positive in four cases. As for the blood cultures, they were positive in 13 cases. The germs found were Streptococcus in 10 cases and staphylococcus in three cases. Echocardiography had revealed vegetations in 18 cases. These vegetations were localized on the mitral in nine cases. Multiple locations were found in four cases. Underlying heart disease was dominated by rheumatic valve disease (68.4%), healthy heart forms were found in two cases. Treatment consisted of antibiotics, antipyretic treatment and that of heart failure as appropriate. The evolution was marked by five deaths (26.3%) in an array of septic shock. Death was more important in congenital heart disease.
CONCLUSION: Infective endocarditis of the child is common in our practice. The clinical syndrome is common infectious. Streptococcus and Staphylococcus are the two germs found. The main door is dental. Hence, dental care should be promoted for better prevention of infective endocarditis in our context.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Afrique subsaharienne; Burkina Faso; Child; Endocardite infectieuse; Enfant; Infectious endocarditis; Sub-Saharan Africa

Mesh:

Year:  2013        PMID: 23578437     DOI: 10.1016/j.ancard.2013.02.004

Source DB:  PubMed          Journal:  Ann Cardiol Angeiol (Paris)        ISSN: 0003-3928


  3 in total

Review 1.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

2.  Infective endocarditis in Ethiopian children: a hospital based review of cases in Addis Ababa.

Authors:  Tamirat Moges; Etsegenet Gedlu; Petros Isaakidis; Ajay Kumar; Rafael Van Den Berge; Mohammed Khogali; Amha Mekasha; Sven Gudmund Hinderaker
Journal:  Pan Afr Med J       Date:  2015-01-28

Review 3.  Infective endocarditis by HACEK: a review.

Authors:  Mansoor Khaledi; Fatemeh Sameni; Hamed Afkhami; Jaber Hemmati; Aram Asareh Zadegan Dezfuli; Mohammad-Javad Sanae; Majid Validi
Journal:  J Cardiothorac Surg       Date:  2022-08-19       Impact factor: 1.522

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.